The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomised open-label phase II study of induction standard of care fulvestrant and CDK4/6 inhibition with addition of ipatasertib in metastatic ER+/HER2- breast cancer patients without circulating tumour (ct) DNA suppression (FAIM).
 
Alicia Frances Clare Okines
Stock and Other Ownership Interests - AstraZeneca (I)
Honoraria - AstraZeneca; Gilead Sciences; Seagen
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Pfizer; Roche/Genentech; Seagen
Speakers' Bureau - AstraZeneca; Eisai; Gilead Sciences; Lilly; Pfizer; Seagen
Research Funding - Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Europe GmbH; LEO Pharma; Lilly
 
Jeremy Braybrooke
Employment - GenesisCare
Consulting or Advisory Role - Sciensus
 
Iain R. MacPherson
Honoraria - Roche
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Gilead Sciences; In3Bio; Lilly; Merck Sharp & Dohme (UK) Limited; Pfizer; Roche
Speakers' Bureau - Daiichi Sankyo UK Ltd
Research Funding - Allarity Therapeutics (Inst); AstraZeneca (Inst); Byondis (Inst); Celldex (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi/Aventis (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo; Gilead Sciences; Novartis Pharmaceuticals UK Ltd.
 
Dr. Stephanie Sutherland
Honoraria - Seagen
Consulting or Advisory Role - Roche
 
Sacha Jon Howell
Consulting or Advisory Role - Lilly O.; Pfizer
Speakers' Bureau - Pfizer
Research Funding - Lilly O.
 
Duncan Wheatley
Honoraria - Gilead/Forty Seven; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Novartis; pfizer; Roche
Travel, Accommodations, Expenses - Roche
 
Simon Waters
Honoraria - Novartis Pharmaceuticals UK Ltd.
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Novartis Pharmaceuticals UK Ltd.; Sanofi/Aventis
 
Rebecca Roylance
Leadership - Google health (I)
Honoraria - Daiichi Sankyo Europe GmbH; Daiichi Sankyo/Astra Zeneca; Daiichi Sankyo/Astra Zeneca
Consulting or Advisory Role - Daiichi Sankyo Europe GmbH; Daiichi Sankyo/Astra Zeneca; Iqvia; Lilly
Travel, Accommodations, Expenses - BMS; Daiichi Sankyo Europe GmbH; Daiichi Sankyo Europe GmbH; Roche/Genentech
 
Richard D. Baird
Consulting or Advisory Role - AstraZeneca (Inst); Daiichi Sankyo (Inst); Molecular Partners (Inst); Novartis (Inst); Roche/Genentech (Inst); Shionogi (Inst)
Research Funding - AstraZeneca (Inst); Biomarin (Inst); Boehringer Ingelheim (Inst); Carrick Therapeutics (Inst); G1 Therapeutics (Inst); Genentech (Inst); Molecular Partners (Inst); Roche (Inst); Sanofi (Inst); Shionogi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo; Molecular Partners; Shionogi
 
Olga Oikonomidou
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo Pharmaceutical; Eisai; Exact Sciences; Gilead Sciences; Lilly O.; Merck; Novartis; Pfizer; Roche; Sanofi; Tesaro
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Eisai; Lilly O.; Novartis; Pfizer; Roche
 
Carlo Palmieri
Honoraria - Pfizer
Consulting or Advisory Role - Daiichi-Sankyo; Lilly; Novartis; Pfizer; Seagen
Research Funding - Daiichi-Sankyo; Pfizer
Travel, Accommodations, Expenses - Roche
 
Mark Harries
Speakers' Bureau - Exact Sciences; MSD; Pfizer; Roche
Travel, Accommodations, Expenses - Roche
 
Catherine Harper-Wynne
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Lilly O.; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Novartis; Pfizer; Roche
(OPTIONAL) Uncompensated Relationships - Novartis; Pfizer
 
Amna Sheri
Honoraria - AstraZeneca; Roche
Consulting or Advisory Role - Pfizer
 
Sarah Khan
No Relationships to Disclose
 
Catey Bunce
No Relationships to Disclose
 
Kabir Mohammed
No Relationships to Disclose
 
Dymphna Lee
No Relationships to Disclose
 
Nicholas C. Turner
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Exact Sciences; Gilead Sciences; GlaxoSmithKline; Guardant Health; Inivata; Inivata; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Relay therapeutics; Repare Therapeutics; Roche; Zentalis
Research Funding - AstraZeneca (Inst); Guardant Health (Inst); Inivata (Inst); InVitae (Inst); Merck Sharpe and Dohme (Inst); Natera (Inst); Personalis (Inst); Pfizer (Inst); Roche (Inst)